Skip to main content

Table 2 Clinical pathological characteristics of the case series

From: Promoter methylation of tumor suppressor genes in pre-neoplastic lesions; potential marker of disease recurrence

 

Total n (%)

Disease recurrence n (%)

No. of disease recurrence n (%)

P

Gender

    

 Male

56 (71.8)

24 (77.4)

32 (68.1)

 

 Female

22 (28.2)

7 (22.6)

15 (31.9)

0.523

Median age, years (range)

    

 Male

61 (42–85)

64 (48–85)

61 (42–79)

0.263

 Female

66 (40–81)

63 (51–72)

66 (40–81)

0.972

Risk of recurrence

    

 High risk

43 (55.1)

16 (51.6)

27 (57.4)

 

 Low risk

35 (44.9)

15 (48.4)

20 (42.6)

0.784

Dysplasia

    

 Low (low and medium) grade

61 (78.2)

26 (83.9)

35 (74.5)

 

 High grade

17 (21.8)

5 (16.1)

12 (25.5)

0.481

Lesion dimension

    

 0–0.9 cm

9 (11.5)

3 (9.7)

6 (12.8)

 

 ≥ 1 cm

29 (37.2)

11 (35.5)

18 (38.3)

 

 Not specified

40 (51.3)

17 (54.8)

23 (48.9)

1.000

Lesion localization

    

 Ascending colon

19 (24.4)

10 (32.3)

9 (19.1)

 

 Descending colon

37 (47.4)

9 (29.0)

28 (59.6)

 

 Mixed

22 (28.2)

12 (38.7)

10 (21.3)

0.015

Adenoma morphology

    

 Tubular

46 (59.0)

19 (61.3)

27 (57.4)

 

 Villous

3 (3.8)

0

3 (6.4)

 

 Tubulovillous (mixed)

29 (37.2)

12 (38.7)

17 (36.2)

0.441